115 Publications (Page 3 of 5)
2012
A phase II and biomarker study (MET111644) of the dual Met/VEGFR-2 inhibitor foretinib in patients with sporadic and hereditary papillary renal cell carcinoma: Final efficacy, safety, and PD results
Choueiri, Toni K⋅Choueiri, Toni K⋅Vaishampayan, Ulka N⋅Vaishampayan, Ulka N⋅Rosenberg, Jonathan E⋅Rosenberg, Jonathan E⋅Logan, Theodore⋅Logan, Theodore⋅Harzstark, Andrea Lynne⋅Harzstark, Andrea Lynne⋅Rini, Brian I⋅Rini, Brian I⋅Srinivas, Sandy⋅Srinivas, Sandy⋅Adams, Laurel M⋅Adams, Laurel M⋅Sherman, Laurie Jill⋅Sherman, Laurie Jill⋅Ottesen, Lone Harild⋅Ottesen, Lone Harild⋅Mc Dermott, David F⋅McDermott, David F⋅Bottaro, Donald P⋅Bottaro, Donald P⋅Linehan, W Marston⋅Linehan, W. Marston⋅Srinivasan, Ramaprasad and Srinivasan, Ramaprasad
Journal of Clinical Oncology, vol. 30, (no. 5_suppl), pp. 355, 2012-02-10. | Journal Article
 
A phase II study of 2-methoxyestradiol nanocrystal colloidal dispersion alone and in combination with sunitinib malate in patients with metastatic renal cell carcinoma progressing on sunitinib malate
Bruce, Justine Y⋅Bruce, Justine⋅Bruce, Justine⋅Eickhoff, Jens⋅Eickhoff, Jens⋅Eickhoff, Jens⋅Pili, Roberto⋅Pili, Roberto⋅Pili, Roberto⋅Logan, Theodore⋅Logan, Theodore⋅Logan, Theodore⋅Carducci, Michael⋅Carducci, Michael⋅Carducci, Michael⋅Arnott, Jamie⋅Arnott, Jamie⋅Arnott, Jamie⋅Treston, Anthony⋅Treston, Anthony⋅Treston, Anthony⋅Wilding, George⋅Wilding, George⋅Wilding, George⋅Liu, Glenn⋅Liu, Glenn and Liu, Glenn
Investigational New Drugs, vol. 30, (no. 2), pp. 794-802, Apr 2012. | Journal Article
 
Correlation of germline MET mutation with response to the dual Met/VEGFR-2 inhibitor foretinib in patients with sporadic and hereditary papillary renal cell carcinoma: Results from a multicenter phase II study (MET111644)
Srinivasan, Ramaprasad⋅Srinivasan, Ramaprasad⋅Bottaro, Donald P⋅Bottaro, Donald P⋅Choueiri, Toni K⋅Choueiri, Toni K⋅Vaishampayan, Ulka N⋅Vaishampayan, Ulka N⋅Rosenberg, Jonathan E⋅Rosenberg, Jonathan E⋅Logan, Theodore⋅Logan, Theodore⋅Harzstark, Andrea Lynne⋅Harzstark, Andrea Lynne⋅Rini, Brian I⋅Rini, Brian I⋅Srinivas, Sandy⋅Srinivas, Sandy⋅Adams, Laurel M⋅Adams, Laurel M⋅Laubscher, Kevin⋅Laubscher, Kevin⋅Ottesen, Lone Harild⋅Ottesen, Lone Harild⋅McDermott, David F⋅Mc Dermott, David F⋅Linehan, W Marston and Linehan, W. Marston
Journal of Clinical Oncology, vol. 30, (no. 5_suppl), pp. 372, 2012-02-10. | Journal Article
 
Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial.
Margolin, Kim⋅Margolin, Kim⋅Ernstoff, Marc S⋅Ernstoff, Marc S⋅Hamid, Omid⋅Hamid, Omid⋅Lawrence, Donald⋅Lawrence, Donald⋅Mc Dermott, David F⋅Mc Dermott, David⋅Puzanov, Igor J⋅Puzanov, Igor⋅Wolchok, Jedd⋅Wolchok, Jedd D⋅Clark, Joseph⋅Clark, Joseph I⋅Sznol, Mario⋅Sznol, Mario⋅Logan, Theodore F⋅Logan, Theodore F⋅Richards, Jon⋅Richards, Jon⋅Michener, Tracy⋅Michener, Tracy⋅Balogh, Agnes⋅Balogh, Agnes⋅Heller, Kevin N⋅Heller, Kevin N⋅Hodi, F S and Hodi, F S
The lancet oncology, vol. 13, (no. 5), pp. 459-65, 2012/May. | Journal Article
 
Phase I/II study of a BNC105P/everolimus regimen for progressive metastatic renal cell carcinoma (mRCC) following prior tyrosine kinase inhibitors (Hoosier Oncology Group)
Hutson, Thomas E⋅Dang, Long H⋅Lauer, Richard C⋅Starodub, Alexander⋅Hauke, Ralph J⋅Logan, Theodore⋅Bylow, Kathryn A⋅Galsky, Matt D⋅Bibby, David C⋅Kremmidiotis, Gabriel⋅Doolin, Elizabeth E⋅Lavranos, Tina C⋅Leske, Annabell F⋅Hahn, Noah M⋅Sonpavde, Guru⋅Sweeney, Christopher and Sarantopoulos, John
Journal of Clinical Oncology, vol. 30, (no. 5_suppl), pp. 373, 2012-02-10. | Journal Article
 
Phase II study combining personalized dendritic cell (DC)-based therapy, AGS-003, with sunitinib in metastatic renal cell carcinoma (mRCC).
Figlin, Robert A⋅Amin, Asim⋅Dudek, Arkadiusz⋅Logan, Theodore⋅Lance, Raymond S⋅Holzbeierlein, Jeffrey M⋅Master, Viraj A⋅Pal, Sumanta Kumar⋅Gamble, Alicia H⋅DeBenedette, Mark⋅Tcherepanova, Irina Y⋅Williams, W Lee⋅Plessinger, Doug⋅Miesowicz, Fred and Nicolette, Charles A
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 30, (no. 5_suppl), pp. 348, February 10, 2012. | Journal Article
 
Phase I results of a phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinoma (mRCC) patients previously treated with VEGFR tyrosine kinase inhibitors
Hutson, Thomas E⋅Dang, Long H⋅Lauer, Richard C⋅Starodub, Alexander⋅Hauke, Ralph J⋅Galsky, Matt D⋅Bylow, Kathryn A⋅Logan, Theodore⋅Cowey, Charles Lance⋅Bibby, David C⋅Kremmidiotis, Gabriel⋅Doolin, Elizabeth E⋅Lavranos, Tina C⋅Sonpavde, Guru⋅Hahn, Noah M⋅Sweeney, Christopher and Sarantopoulos, John
Journal of Clinical Oncology, vol. 30, (no. 15_suppl), pp. 4603, 2012-05-20. | Journal Article
 
Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion.
Ribas, Antoni⋅Chesney, Jason A⋅Gordon, Michael S⋅Abernethy, Amy P⋅Logan, Theodore F⋅Lawson, David H⋅Chmielowksi, Bartosz⋅Glaspy, John A⋅Lewis, Karl⋅Huang, Bo⋅Wang, Erjian⋅Hsyu, Poe-Hirr⋅Gomez-Navarro, Jesus⋅Gerhardt, Diana⋅Marshall, Margaret A and Gonzalez, Rene
Journal of translational medicine, vol. 10, pp. 236, 2012. | Journal Article
2011
Drug-related pneumonitis in patients with advanced renal cell carcinoma treated with temsirolimus.
Maroto, Jose P⋅Hudes, Gary R⋅Dutcher, Janice P⋅Logan, Theodore F⋅White, Charles S⋅Krygowski, Mizue⋅Cincotta, Maria⋅Shapiro, Mark⋅Duran, Ignacio and Berkenblit, Anna
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 29, (no. 13), pp. 1750-6, 2011/May/1. | Journal Article
2010
A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin (alpha sub v)(beta sub 3), (plus or minus) dacarbazine in patients with stage IV metastatic melanoma
Hersey, Peter⋅Gonzalez, Rene⋅O'Day, Steven⋅Weber, Robert⋅Bedikian, Agop⋅Sosman, Jeffrey⋅Kirkwood, John⋅Hammershaimb, Luz⋅Richards, Jon⋅Sharfman, William⋅Buzoianu, Manuela and Logan, Theodore
Cancer, vol. 116, (no. 6), pp. 1526, 20100315. | Journal Article
 
A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin alpha(v)beta(3), + or - dacarbazine in patients with stage IV metastatic melanoma.
Hersey, Peter⋅Sosman, Jeffrey A⋅O'Day, Steven⋅Richards, Jon⋅Bedikian, Agop Y⋅Gonzalez, Rene⋅Sharfman, William⋅Weber, Robert⋅Logan, Theodore F⋅Buzoianu, Manuela⋅Hammershaimb, Luz and Kirkwood, John M
Cancer, vol. 116, (no. 6), pp. 1526-34, 2010/Mar/15. | Journal Article
2009
A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma
Tarhini, Ahmad⋅Millward, Michael⋅Mainwaring, Paul⋅Kefford, Richard⋅Logan, Theodore F⋅Pavlick, Anna⋅Kathman, Steven J⋅Laubscher, Kevin H⋅Dar, Mohammed M and Kirkwood, John M
Cancer, vol. 115, (no. 4), pp. 859-868, 2009. | Journal Article
 
Prognostic Implications of Polymorphisms and Interleukin-2 Therapy for Renal Cell Carcinoma
Gardner, Thomas A⋅Gardner, Thomas⋅Logan, Theodore and Logan, Theodore
Journal of Urology, The, vol. 182, (no. 2), pp. 426, 2009. | Journal Article
2008
A Dose-Escalation Study of Recombinant Human Interleukin-18 Using Two Different Schedules of Administration in Patients with Cancer
Robertson, Michael J⋅Kirkwood, John M⋅Logan, Theodore F⋅Koch, Kevin M⋅Kathman, Steven⋅Kirby, Lyndon C⋅Bell, William N⋅Thurmond, Linda M⋅Weisenbach, Jill and Dar, Mohammed M
Clinical Cancer Research, vol. 14, (no. 11), pp. 3462-3469, 2008. | Journal Article
 
Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma: a phase II Cytokine Working Group study.
Atkins, Michael B⋅Sosman, Jeffrey A⋅Agarwala, Sanjiv⋅Logan, Theodore⋅Clark, Joseph⋅Ernstoff, Marc S⋅Lawson, David⋅Dutcher, Janice P⋅Weiss, Geoffrey⋅Curti, Brendan and Margolin, Kim
Cancer, vol. 113, (no. 8), pp. 2139-45, 2008/Oct/15. | Journal Article
2007
Phase I/II trial of outpatient PEG-interferon with interleukin-2 in advanced renal cell carcinoma: a cytokine working group study.
Clark, Joseph⋅Mehrabi, Jessica⋅Sosman, Jeffrey A⋅Logan, Theodore F⋅Margolin, Kim⋅Dutcher, Janice P⋅Urba, Walter J⋅Ernstoff, Marc S⋅Mc Dermott, David F⋅Lau, Ann M and Atkins, Michael B
Journal of immunotherapy (Hagerstown, Md. : 1997), vol. 30, (no. 8), pp. 839-46, 2007 Nov-Dec. | Journal Article
 
Urticaria and Angioedema in Renal Cell Cancer Patients Treated with IL-2
Logan, Theodore F⋅Strippoli, Giovanni and Levine, Macy I
Cancer Investigation, vol. 25, (no. 7), pp. 584-588, 2007. | Journal Article
2006
Adoptive Immunotherapy by Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Carcinoma: A CALGB Intergroup Phase II Study
Rini, Brian I⋅Rini, Brian I⋅Halabi, Susan⋅Halabi, Susan⋅Barrier, Robert⋅Barrier, Robert⋅Margolin, Kim⋅Margolin, Kim A⋅Avigan, David E⋅Avigan, David⋅Logan, Theodore⋅Logan, Theodore⋅Stadler, Walter M⋅Stadler, Walter M⋅McCarthy, Philip L⋅McCarthy, Philip L⋅Linker, Charles A⋅Linker, Charles A⋅Small, Eric J and Small, Eric J
Biology of Blood and Marrow Transplantation, vol. 12, (no. 7), pp. 785, 2006. | Journal Article
 
Clinical and Biological Effects of Recombinant Human Interleukin-18 Administered by Intravenous Infusion to Patients with Advanced Cancer
Robertson, Michael J⋅Mier, James W⋅Logan, Theodore F⋅Atkins, Michael B⋅Koon, Henry B⋅Koch, Kevin M⋅Kathman, Steven⋅Pandite, Lini N⋅Oei, Coreen⋅Kirby, Lyndon C⋅Jewell, Roxanne C⋅Bell, William N⋅Thurmond, Linda M⋅Weisenbach, Jill⋅Roberts, Suzanne and Dar, Mohammed M
Clinical Cancer Research, vol. 12, (no. 14), pp. 4265-4273, 2006. | Journal Article
 
Interleukins 18 and 21: biology, mechanisms of action, toxicity, and clinical activity.
Logan, Theodore F and Robertson, Michael J
Current oncology reports, vol. 8, (no. 2), pp. 114-9, 2006/Mar. | Journal Article
2005
Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
Wagner, Jeffrey D⋅Schauwecker, Donald⋅Davidson, Darrell⋅Logan, Theodore⋅Coleman, John J⋅Hutchins, Gary⋅Love, Charlene⋅Wenck, Stacie and Daggy, Joanne
Cancer, vol. 104, (no. 3), pp. 570-9, 2005/Aug/1. | Journal Article
 
Inefficacy of F‐18 fluorodeoxy‐D‐glucose‐positron emission tomography scans for initial evaluation in early‐stage cutaneous melanoma
Wagner, Jeffrey D⋅Wagner, Jeffrey D⋅Wagner, Jeffrey D⋅Wagner, Jeffrey D⋅Schauwecker, Donald⋅Schauwecker, Donald⋅Schauwecker, Donald⋅Schauwecker, Donald⋅Davidson, Darrell⋅Davidson, Darrell⋅Davidson, Darrell⋅Davidson, Darrell⋅Logan, Theodore⋅Logan, Theodore⋅Logan, Theodore⋅Logan, Theodore⋅Coleman, John J⋅Coleman, John J⋅Coleman, John J⋅Coleman, John J⋅Hutchins, Gary⋅Hutchins, Gary⋅Hutchins, Gary⋅Hutchins, Gary⋅Love, Charlene⋅Love, Charlene⋅Love, Charlene⋅Love, Charlene⋅Wenck, Stacie⋅Wenck, Stacie⋅Wenck, Stacie⋅Wenck, Stacie⋅Daggy, Joanne⋅Daggy, Joanne⋅Daggy, Joanne and Daggy, Joanne
Cancer, vol. 104, (no. 3), pp. 579, 1 August 2005. | Journal Article
 
Pegylated Arginine Deiminase Treatment of Patients With Metastatic Melanoma: Results From Phase I and II Studies
Ascierto, Paolo⋅Scala, Stefania⋅Castello, Giuseppe⋅Daponte, Antonio⋅Simeone, Ester⋅Ottaiano, Alessandro⋅Beneduce, Gerardo⋅Rosa, Vincenzo⋅Izzo, Francesco⋅Melucci, Maria⋅Ensor, C.⋅Prestayko, Archie⋅Holtsberg, Frederick⋅Bomalaski, John⋅Clark, Mike⋅Savaraj, Niramol⋅Feun, Lynn and Logan, Theodore
Journal of Clinical Oncology, vol. 23, (no. 30), pp. 7668, 20051020. | Journal Article
 
Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma.
Mc Dermott, David F⋅Regan, Meredith M⋅Clark, Joseph⋅Flaherty, Lawrence E⋅Weiss, Geoffery R⋅Logan, Theodore F⋅Kirkwood, John M⋅Gordon, Michael S⋅Sosman, Jeffrey A⋅Ernstoff, Marc S⋅Tretter, Christopher P⋅Urba, Walter J⋅Smith, John W⋅Margolin, Kim⋅Mier, James W⋅Gollob, Jared A⋅Dutcher, Janice P and Atkins, Michael B
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 23, (no. 1), pp. 133-41, 2005/Jan/1. | Journal Article
 
Transcriptional Profiles in Peripheral Blood Mononuclear Cells Prognostic of Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma
Burczynski, Michael E⋅Twine, Natalie C⋅Dukart, Gary⋅Marshall, Bonnie⋅Hidalgo, Manuel⋅Stadler, Walter M⋅Logan, Theodore F⋅Dutcher, Janice⋅Hudes, Gary R⋅Trepicchio, William L⋅Strahs, Andrew⋅Immermann, Fred⋅Slonim, Donna and Dorner, Andrew J
Clinical Cancer Research, vol. 11, (no. 3), pp. 1181-1189, 2005. | Journal Article